Plain-English translation of NCT05726383 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a medication called Iscador® P, made from mistletoe extract, to help prevent bone cancer (osteosarcoma) from returning in the lungs after you've had surgery to remove it. The medication is given as injections three times per week for one year. The goal is to see if this treatment can help you stay cancer-free longer.
Bone cancer that comes back in the lungs after surgery is very serious, and current treatments don't always work well. Researchers want to know if this medication can strengthen your immune system to fight any remaining cancer cells and prevent the cancer from returning.
You likely qualify if…
You likely don't qualify if…
You will receive injections of the medication three times per week (on Mondays, Wednesdays, and Fridays) into your belly or thigh for 52 weeks (one year). The doses start very small and gradually increase to find the right level for your body. During the year, you'll have regular CT scan imaging to check that the cancer hasn't come back, and you'll have blood tests to make sure the treatment is working safely.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States